The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Biomedical Exoskeletons Market Research Report 2024

Global Biomedical Exoskeletons Market Research Report 2024

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1763154

No of Pages : 114

Ask Your Query

Synopsis
Robotic exoskeletons are wearable electromechanical devices that have been developed as augmentative devices to enhance the physical performance of the wearer or as orthotic devices for gait rehabilitation or locomotion assistance. These enable users with appropriate physical abilities to stand, walk, climb stairs and perform ADL. Biomedical exoskeletons are designed for rehabilitation or motion assistance purposes. Exoskeletons can be driven in many ways, but most commonly they are electrically, mechanically, or hydraulically driven. The motors, sensors, and servo drives in the exoskeleton act as components of the human body. The nervous system, or in this case the servo drives, instruct the motors to move as the human brain does with muscles. The encoders monitor and respond to the motion.

Global Biomedical Exoskeletons market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Biomedical Exoskeletons market research.

Key manufacturers engaged in the Biomedical Exoskeletons industry include ReWalk, Ekso Bionics, Rex Bionics, Cyberdyne, Sarcos, Novanta, Hocoma, Panasonic and Myomo, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Biomedical Exoskeletons were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Biomedical Exoskeletons market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Biomedical Exoskeletons market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • ReWalk
  • Ekso Bionics
  • Rex Bionics
  • Cyberdyne
  • Sarcos
  • Novanta
  • Hocoma
  • Panasonic
  • Myomo
  • Bionik Laboratories Corp
  • B-Temia
  • Samsung
  • Honda Motor
  • AposHealth
  • iWALKFree
  • Trexo Robotics
  • THERA-Trainer
  • Motorika
  • Össur
  • AlterG
  • Toyota Motor
  • Boinic Power
  • OPUM Technologies

Segment by Type

  • Exoskeleton
  • Pediatric Exoskeletons

Segment by Application

  • Orthopedics
  • Neurology

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Biomedical Exoskeletons report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Biomedical Exoskeletons Market Overview
1.1 Product Overview and Scope of Biomedical Exoskeletons
1.2 Biomedical Exoskeletons Segment by Type
1.2.1 Global Biomedical Exoskeletons Market Value Comparison by Type (2023-2029)
1.2.2 Exoskeleton
1.2.3 Pediatric Exoskeletons
1.3 Biomedical Exoskeletons Segment by Application
1.3.1 Global Biomedical Exoskeletons Market Value by Application: (2023-2029)
1.3.2 Orthopedics
1.3.3 Neurology
1.4 Global Biomedical Exoskeletons Market Size Estimates and Forecasts
1.4.1 Global Biomedical Exoskeletons Revenue 2018-2029
1.4.2 Global Biomedical Exoskeletons Sales 2018-2029
1.4.3 Global Biomedical Exoskeletons Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Biomedical Exoskeletons Market Competition by Manufacturers
2.1 Global Biomedical Exoskeletons Sales Market Share by Manufacturers (2018-2023)
2.2 Global Biomedical Exoskeletons Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Biomedical Exoskeletons Average Price by Manufacturers (2018-2023)
2.4 Global Biomedical Exoskeletons Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Biomedical Exoskeletons, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Biomedical Exoskeletons, Product Type & Application
2.7 Biomedical Exoskeletons Market Competitive Situation and Trends
2.7.1 Biomedical Exoskeletons Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Biomedical Exoskeletons Players Market Share by Revenue
2.7.3 Global Biomedical Exoskeletons Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Biomedical Exoskeletons Retrospective Market Scenario by Region
3.1 Global Biomedical Exoskeletons Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Biomedical Exoskeletons Global Biomedical Exoskeletons Sales by Region: 2018-2029
3.2.1 Global Biomedical Exoskeletons Sales by Region: 2018-2023
3.2.2 Global Biomedical Exoskeletons Sales by Region: 2024-2029
3.3 Global Biomedical Exoskeletons Global Biomedical Exoskeletons Revenue by Region: 2018-2029
3.3.1 Global Biomedical Exoskeletons Revenue by Region: 2018-2023
3.3.2 Global Biomedical Exoskeletons Revenue by Region: 2024-2029
3.4 North America Biomedical Exoskeletons Market Facts & Figures by Country
3.4.1 North America Biomedical Exoskeletons Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Biomedical Exoskeletons Sales by Country (2018-2029)
3.4.3 North America Biomedical Exoskeletons Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Biomedical Exoskeletons Market Facts & Figures by Country
3.5.1 Europe Biomedical Exoskeletons Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Biomedical Exoskeletons Sales by Country (2018-2029)
3.5.3 Europe Biomedical Exoskeletons Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Biomedical Exoskeletons Market Facts & Figures by Country
3.6.1 Asia Pacific Biomedical Exoskeletons Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Biomedical Exoskeletons Sales by Country (2018-2029)
3.6.3 Asia Pacific Biomedical Exoskeletons Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Biomedical Exoskeletons Market Facts & Figures by Country
3.7.1 Latin America Biomedical Exoskeletons Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Biomedical Exoskeletons Sales by Country (2018-2029)
3.7.3 Latin America Biomedical Exoskeletons Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Biomedical Exoskeletons Market Facts & Figures by Country
3.8.1 Middle East and Africa Biomedical Exoskeletons Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Biomedical Exoskeletons Sales by Country (2018-2029)
3.8.3 Middle East and Africa Biomedical Exoskeletons Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Biomedical Exoskeletons Sales by Type (2018-2029)
4.1.1 Global Biomedical Exoskeletons Sales by Type (2018-2023)
4.1.2 Global Biomedical Exoskeletons Sales by Type (2024-2029)
4.1.3 Global Biomedical Exoskeletons Sales Market Share by Type (2018-2029)
4.2 Global Biomedical Exoskeletons Revenue by Type (2018-2029)
4.2.1 Global Biomedical Exoskeletons Revenue by Type (2018-2023)
4.2.2 Global Biomedical Exoskeletons Revenue by Type (2024-2029)
4.2.3 Global Biomedical Exoskeletons Revenue Market Share by Type (2018-2029)
4.3 Global Biomedical Exoskeletons Price by Type (2018-2029)
5 Segment by Application
5.1 Global Biomedical Exoskeletons Sales by Application (2018-2029)
5.1.1 Global Biomedical Exoskeletons Sales by Application (2018-2023)
5.1.2 Global Biomedical Exoskeletons Sales by Application (2024-2029)
5.1.3 Global Biomedical Exoskeletons Sales Market Share by Application (2018-2029)
5.2 Global Biomedical Exoskeletons Revenue by Application (2018-2029)
5.2.1 Global Biomedical Exoskeletons Revenue by Application (2018-2023)
5.2.2 Global Biomedical Exoskeletons Revenue by Application (2024-2029)
5.2.3 Global Biomedical Exoskeletons Revenue Market Share by Application (2018-2029)
5.3 Global Biomedical Exoskeletons Price by Application (2018-2029)
6 Key Companies Profiled
6.1 ReWalk
6.1.1 ReWalk Corporation Information
6.1.2 ReWalk Description and Business Overview
6.1.3 ReWalk Biomedical Exoskeletons Sales, Revenue and Gross Margin (2018-2023)
6.1.4 ReWalk Biomedical Exoskeletons Product Portfolio
6.1.5 ReWalk Recent Developments/Updates
6.2 Ekso Bionics
6.2.1 Ekso Bionics Corporation Information
6.2.2 Ekso Bionics Description and Business Overview
6.2.3 Ekso Bionics Biomedical Exoskeletons Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Ekso Bionics Biomedical Exoskeletons Product Portfolio
6.2.5 Ekso Bionics Recent Developments/Updates
6.3 Rex Bionics
6.3.1 Rex Bionics Corporation Information
6.3.2 Rex Bionics Description and Business Overview
6.3.3 Rex Bionics Biomedical Exoskeletons Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Rex Bionics Biomedical Exoskeletons Product Portfolio
6.3.5 Rex Bionics Recent Developments/Updates
6.4 Cyberdyne
6.4.1 Cyberdyne Corporation Information
6.4.2 Cyberdyne Description and Business Overview
6.4.3 Cyberdyne Biomedical Exoskeletons Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Cyberdyne Biomedical Exoskeletons Product Portfolio
6.4.5 Cyberdyne Recent Developments/Updates
6.5 Sarcos
6.5.1 Sarcos Corporation Information
6.5.2 Sarcos Description and Business Overview
6.5.3 Sarcos Biomedical Exoskeletons Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Sarcos Biomedical Exoskeletons Product Portfolio
6.5.5 Sarcos Recent Developments/Updates
6.6 Novanta
6.6.1 Novanta Corporation Information
6.6.2 Novanta Description and Business Overview
6.6.3 Novanta Biomedical Exoskeletons Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Novanta Biomedical Exoskeletons Product Portfolio
6.6.5 Novanta Recent Developments/Updates
6.7 Hocoma
6.6.1 Hocoma Corporation Information
6.6.2 Hocoma Description and Business Overview
6.6.3 Hocoma Biomedical Exoskeletons Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Hocoma Biomedical Exoskeletons Product Portfolio
6.7.5 Hocoma Recent Developments/Updates
6.8 Panasonic
6.8.1 Panasonic Corporation Information
6.8.2 Panasonic Description and Business Overview
6.8.3 Panasonic Biomedical Exoskeletons Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Panasonic Biomedical Exoskeletons Product Portfolio
6.8.5 Panasonic Recent Developments/Updates
6.9 Myomo
6.9.1 Myomo Corporation Information
6.9.2 Myomo Description and Business Overview
6.9.3 Myomo Biomedical Exoskeletons Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Myomo Biomedical Exoskeletons Product Portfolio
6.9.5 Myomo Recent Developments/Updates
6.10 Bionik Laboratories Corp
6.10.1 Bionik Laboratories Corp Corporation Information
6.10.2 Bionik Laboratories Corp Description and Business Overview
6.10.3 Bionik Laboratories Corp Biomedical Exoskeletons Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Bionik Laboratories Corp Biomedical Exoskeletons Product Portfolio
6.10.5 Bionik Laboratories Corp Recent Developments/Updates
6.11 B-Temia
6.11.1 B-Temia Corporation Information
6.11.2 B-Temia Biomedical Exoskeletons Description and Business Overview
6.11.3 B-Temia Biomedical Exoskeletons Sales, Revenue and Gross Margin (2018-2023)
6.11.4 B-Temia Biomedical Exoskeletons Product Portfolio
6.11.5 B-Temia Recent Developments/Updates
6.12 Samsung
6.12.1 Samsung Corporation Information
6.12.2 Samsung Biomedical Exoskeletons Description and Business Overview
6.12.3 Samsung Biomedical Exoskeletons Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Samsung Biomedical Exoskeletons Product Portfolio
6.12.5 Samsung Recent Developments/Updates
6.13 Honda Motor
6.13.1 Honda Motor Corporation Information
6.13.2 Honda Motor Biomedical Exoskeletons Description and Business Overview
6.13.3 Honda Motor Biomedical Exoskeletons Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Honda Motor Biomedical Exoskeletons Product Portfolio
6.13.5 Honda Motor Recent Developments/Updates
6.14 AposHealth
6.14.1 AposHealth Corporation Information
6.14.2 AposHealth Biomedical Exoskeletons Description and Business Overview
6.14.3 AposHealth Biomedical Exoskeletons Sales, Revenue and Gross Margin (2018-2023)
6.14.4 AposHealth Biomedical Exoskeletons Product Portfolio
6.14.5 AposHealth Recent Developments/Updates
6.15 iWALKFree
6.15.1 iWALKFree Corporation Information
6.15.2 iWALKFree Biomedical Exoskeletons Description and Business Overview
6.15.3 iWALKFree Biomedical Exoskeletons Sales, Revenue and Gross Margin (2018-2023)
6.15.4 iWALKFree Biomedical Exoskeletons Product Portfolio
6.15.5 iWALKFree Recent Developments/Updates
6.16 Trexo Robotics
6.16.1 Trexo Robotics Corporation Information
6.16.2 Trexo Robotics Biomedical Exoskeletons Description and Business Overview
6.16.3 Trexo Robotics Biomedical Exoskeletons Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Trexo Robotics Biomedical Exoskeletons Product Portfolio
6.16.5 Trexo Robotics Recent Developments/Updates
6.17 THERA-Trainer
6.17.1 THERA-Trainer Corporation Information
6.17.2 THERA-Trainer Biomedical Exoskeletons Description and Business Overview
6.17.3 THERA-Trainer Biomedical Exoskeletons Sales, Revenue and Gross Margin (2018-2023)
6.17.4 THERA-Trainer Biomedical Exoskeletons Product Portfolio
6.17.5 THERA-Trainer Recent Developments/Updates
6.18 Motorika
6.18.1 Motorika Corporation Information
6.18.2 Motorika Biomedical Exoskeletons Description and Business Overview
6.18.3 Motorika Biomedical Exoskeletons Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Motorika Biomedical Exoskeletons Product Portfolio
6.18.5 Motorika Recent Developments/Updates
6.19 Össur
6.19.1 Össur Corporation Information
6.19.2 Össur Biomedical Exoskeletons Description and Business Overview
6.19.3 Össur Biomedical Exoskeletons Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Össur Biomedical Exoskeletons Product Portfolio
6.19.5 Össur Recent Developments/Updates
6.20 AlterG
6.20.1 AlterG Corporation Information
6.20.2 AlterG Biomedical Exoskeletons Description and Business Overview
6.20.3 AlterG Biomedical Exoskeletons Sales, Revenue and Gross Margin (2018-2023)
6.20.4 AlterG Biomedical Exoskeletons Product Portfolio
6.20.5 AlterG Recent Developments/Updates
6.21 Toyota Motor
6.21.1 Toyota Motor Corporation Information
6.21.2 Toyota Motor Biomedical Exoskeletons Description and Business Overview
6.21.3 Toyota Motor Biomedical Exoskeletons Sales, Revenue and Gross Margin (2018-2023)
6.21.4 Toyota Motor Biomedical Exoskeletons Product Portfolio
6.21.5 Toyota Motor Recent Developments/Updates
6.22 Boinic Power
6.22.1 Boinic Power Corporation Information
6.22.2 Boinic Power Biomedical Exoskeletons Description and Business Overview
6.22.3 Boinic Power Biomedical Exoskeletons Sales, Revenue and Gross Margin (2018-2023)
6.22.4 Boinic Power Biomedical Exoskeletons Product Portfolio
6.22.5 Boinic Power Recent Developments/Updates
6.23 OPUM Technologies
6.23.1 OPUM Technologies Corporation Information
6.23.2 OPUM Technologies Biomedical Exoskeletons Description and Business Overview
6.23.3 OPUM Technologies Biomedical Exoskeletons Sales, Revenue and Gross Margin (2018-2023)
6.23.4 OPUM Technologies Biomedical Exoskeletons Product Portfolio
6.23.5 OPUM Technologies Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Biomedical Exoskeletons Industry Chain Analysis
7.2 Biomedical Exoskeletons Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Biomedical Exoskeletons Production Mode & Process
7.4 Biomedical Exoskeletons Sales and Marketing
7.4.1 Biomedical Exoskeletons Sales Channels
7.4.2 Biomedical Exoskeletons Distributors
7.5 Biomedical Exoskeletons Customers
8 Biomedical Exoskeletons Market Dynamics
8.1 Biomedical Exoskeletons Industry Trends
8.2 Biomedical Exoskeletons Market Drivers
8.3 Biomedical Exoskeletons Market Challenges
8.4 Biomedical Exoskeletons Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock